ETR:SBS Stratec - SBS Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Stratec SE Please log in to your account or sign up in order to add this asset to your watchlist. €65.90 0.00 (0.00%) (As of 03/23/2023 12:00 AM ET) Add Compare Share Share Today's Range€65.00▼€66.7050-Day Range€65.40▼€90.6052-Week Range€64.70▼€130.60Volume15,270 shsAverage Volume6,253 shsMarket Capitalization$799.37 millionP/E Ratio28.04Dividend Yield1.44%Price Target€90.75 ProfileAnalyst RatingsChartCompetitorsHeadlinesOptions Chain Stratec MarketRank™ ForecastAnalyst RatingN/A0.00 Rating ScoreUpside/Downside37.7% Upside€90.75 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.00Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.58 out of 5 stars 2.0 Analyst's Opinion Price Target Upside/DownsideAccording to analysts' consensus price target of €90.75, Stratec has a forecasted upside of 37.7% from its current price of €65.90.Amount of Analyst CoverageStratec has received no research coverage in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for SBS. Previous Next 1.7 Dividend Strength Dividend YieldStratec pays a meaningful dividend of 1.45%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthStratec does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Stratec is 40.43%. This payout ratio is at a healthy, sustainable level, below 75%. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SBS. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 4 news articles for Stratec this week, compared to 0 articles on an average week. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Stratec insiders have not sold or bought any company stock.Percentage Held by Insiders40.45% of the stock of Stratec is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions46.98% of the stock of Stratec is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Stratec is 28.04, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 123.93.Price to Earnings Ratio vs. SectorThe P/E ratio of Stratec is 28.04, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 99.38.Price to Earnings Growth RatioStratec has a PEG Ratio of 10.43. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioStratec has a P/B Ratio of 3.73. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Stratec (ETR:SBS) StockStratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.Read More Receive SBS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Stratec and its competitors with MarketBeat's FREE daily newsletter. Email Address SBS Stock News HeadlinesMarch 24, 2023 | americanbankingnews.comStratec (ETR:SBS) Given a €80.00 Price Target by Warburg Research AnalystsMarch 20, 2023 | uk.finance.yahoo.comStratec SE (SBS.SG)March 24, 2023 | Legacy Research (Affiliate) (Ad)"Prepare for Five Years of Famine"Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecastMarch 18, 2023 | americanbankingnews.comStratec (ETR:SBS) PT Set at €87.00 by Hauck Aufhäuser Investment BankingMarch 15, 2023 | msn.comGerman Market Update: Three Shares to Buy TodayMarch 10, 2023 | marketwatch.comShares in Stratec Fall After Sales Decline, Lower Margin ForecastJanuary 4, 2023 | finance.yahoo.comCalculating The Intrinsic Value Of Stratec SE (ETR:SBS)December 21, 2022 | finance.yahoo.comStratec SE's (ETR:SBS) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?March 24, 2023 | Legacy Research (Affiliate) (Ad)"Prepare for Five Years of Famine"Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecastDecember 15, 2022 | markets.businessinsider.comEQS-News: STRATEC TO PARTICIPATE IN THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCEDecember 7, 2022 | finance.yahoo.comInvestors Met With Slowing Returns on Capital At Stratec (ETR:SBS)December 1, 2022 | uk.finance.yahoo.comNEW APPOINTMENT TO BOARD OF MANAGEMENT OF STRATEC SEDecember 1, 2022 | fool.comStratec Se (ETR: SBS)November 23, 2022 | finance.yahoo.comStratec (ETR:SBS) investors are sitting on a loss of 33% if they invested a year agoNovember 6, 2022 | finance.yahoo.comStratec SE (ETR:SBS) Just Released Its Third-Quarter Results And Analysts Are Updating Their EstimatesNovember 3, 2022 | markets.businessinsider.comEQS-News: STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2022November 1, 2022 | finance.yahoo.comInstitutional investors own a significant stake of 38% in Stratec SE (ETR:SBS)October 20, 2022 | marketwatch.comStratec Shares Fall After Sales Guidance CutOctober 14, 2022 | finance.yahoo.comStratec SE (SBS.DE)September 13, 2022 | uk.finance.yahoo.comSTRATEC Biomedical AG (SBS.DE)September 9, 2022 | reuters.comSBSG.DE - Stratec SE | Stock Price & Latest News | ReutersAugust 27, 2022 | wsj.comStratec SEAugust 10, 2022 | markets.businessinsider.comDGAP-News: STRATEC REPORTS RESULTS FOR FIRST HALF OF 2022 AND CONFIRMS FINANCIAL GUIDANCEMay 20, 2022 | uk.finance.yahoo.comSTRATEC’S ANNUAL GENERAL MEETING APPROVES DIVIDEND INCREASE AND EXTENSION TO SUPERVISORY BOARDMay 20, 2022 | markets.businessinsider.comDGAP-News: STRATECS ANNUAL GENERAL MEETING APPROVES DIVIDEND INCREASE AND EXTENSION TO SUPERVISORY BOARDMay 5, 2022 | markets.businessinsider.comDGAP-News: STRATEC POSTS GOOD START TO YEAR AND FURTHER SALES GROWTH IN FIRST QUARTER OF 2022March 30, 2022 | markets.businessinsider.comDGAP-News: STRATEC SE: STRATEC GENERATES NEW RECORD SALES AND EARNINGS IN 2021 FINANCIAL YEARSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive SBS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Stratec and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeETR Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolETR:SBS CUSIPN/A CIKN/A Webwww.stratec.com Phone+49-7082-79160FaxN/AEmployees1,282Year FoundedN/APrice Target and Rating Average Stock Price Forecast€90.75 High Stock Price Forecast€119.00 Low Stock Price Forecast€77.00 Forecasted Upside/Downside+37.7%Consensus RatingN/A Rating Score (0-4)0.00 Research Coverage0 Analysts Profitability EPS (Most Recent Fiscal Year)€2.35 Trailing P/E Ratio28.04 Forward P/E Ratio18.31 P/E Growth10.43Net Income$28.33 million Net Margins10.51% Pretax MarginN/A Return on Equity13.67% Return on Assets6.87% Debt Debt-to-Equity Ratio38.79 Current Ratio3.48 Quick Ratio1.65 Sales & Book Value Annual Sales$269.57 million Price / Sales2.97 Cash Flow€2.76 per share Price / Cash Flow23.85 Book Value€17.69 per share Price / Book3.73Miscellaneous Outstanding Shares12,130,000Free FloatN/AMarket Cap$799.37 million OptionableOptionable Beta0.32 Key ExecutivesMr. Marcus Wolfinger (Age 56)Chairman of Board of Management & CEO Comp: $972kDr. Robert Siegle (Age 56)Director of Fin. & HR and Member of Board of Management Comp: $775kDr. Claus Vielsack (Age 56)Director of Product Devel. & Member of Board of Management Comp: $601kMr. Hermann Leistner (Age 77)Founder & Advisor Mr. Jan KeppelerHead of Investor Relations, Sustainability & Corp. CommunicationsMr. Andre LoyDirector of Corp. CommunicationsMr. Roland UtzHead of Supply Chain Management & Sr. VPMore ExecutivesKey CompetitorsDrägerwerk AG & Co. KGaAETR:DRW3Biotest AktiengesellschaftETR:BIORHÖN-KLINIKUM AktiengesellschaftETR:RHKMorphoSysETR:MORGerresheimerETR:GXIView All Competitors SBS Stock - Frequently Asked Questions What is Stratec's stock price forecast for 2023? 0 Wall Street research analysts have issued 1 year target prices for Stratec's shares. Their SBS share price forecasts range from €77.00 to €119.00. On average, they anticipate the company's stock price to reach €90.75 in the next twelve months. This suggests a possible upside of 37.7% from the stock's current price. View analysts price targets for SBS or view top-rated stocks among Wall Street analysts. How have SBS shares performed in 2023? Stratec's stock was trading at €81.10 on January 1st, 2023. Since then, SBS shares have decreased by 18.7% and is now trading at €65.90. View the best growth stocks for 2023 here. Is Stratec a good dividend stock? Stratec (ETR:SBS) pays an annual dividend of €0.95 per share and currently has a dividend yield of 1.45%. The dividend payout ratio is 40.43%. This payout ratio is at a healthy, sustainable level, below 75%. What other stocks do shareholders of Stratec own? Based on aggregate information from My MarketBeat watchlists, some companies that other Stratec investors own include Great Portland Estates (GPOR), Gogo (GOGO), Depomed (DEPO), Cenovus Energy (CVE), China Hydroelectric Corp Foreign (CHC), Bio-Rad Laboratories (BIO), Berkshire Hills Bancorp (BHLB), ASGN (ASGN), Apptio (APTI) and Anadarko Petroleum (APC). What is Stratec's stock symbol? Stratec trades on the ETR under the ticker symbol "SBS." What is Stratec's stock price today? One share of SBS stock can currently be purchased for approximately €65.90. How much money does Stratec make? Stratec (ETR:SBS) has a market capitalization of $799.37 million and generates $269.57 million in revenue each year. The company earns $28.33 million in net income (profit) each year or €2.35 on an earnings per share basis. How many employees does Stratec have? The company employs 1,282 workers across the globe. How can I contact Stratec? Stratec's mailing address is Gewerbestr. 37, BIRKENFELD, 75217, Germany. The official website for the company is www.stratec.com. The company can be reached via phone at +49-7082-79160. This page (ETR:SBS) was last updated on 3/24/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.